• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Mayne Pharma Group Ltd

+ Add to Watchlist

MAYNF:US

0.8150 USD 0.0050 0.61%

As of 20:10:00 ET on 08/01/2014.

Snapshot for Mayne Pharma Group Ltd (MAYNF)

Open: 0.8150 Day's Range: 0.8150 - 0.8150 Volume: 1,500
Previous Close: 0.8200 52wk Range: 0.5400 - 0.9250 1-Yr Rtn: +55.24%

Stock Chart for MAYNF

No chart data available.
  • MAYNF:US 0.8150
  • 1D
  • 1M
  • 1Y
0.8200
Interactive MAYNF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MAYNF

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 29.1895
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) 0.0300
Est. PEG Ratio 0.9386
Market Cap (M USD) 478.12
Shares Outstanding (M) 586.65
30 Day Average Volume 413
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MAYNF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for MAYNF

Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.

Scott RichardsMng Dir/CEO/Exec DirMark CansdaleCFO/Secretary
Danny DragovicDirector:Business Development
More Company Profile & Key Executives for MAYNF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil